Moroccan organisation tackles cardiovascular disease:
This article was originally published in Clinica
Executive Summary
Cardiovascular disease incidence is constantly increasing in Morocco, a leading cardiologist said last week. Speaking at a conference marking the foundation of the "Big Heart" association, Professor Mohammed Arharbi, president of the Moroccan Society of Cardiology, said that this was because patients were unable to afford expensive medicines to combat the disease. Professor Arharbi added that each year some 3,500 neonates in Morocco were born with heart malformations and about 1,000 of these required operations. The "Big Heart" association has been set up by cardiologists and NGOs to support poor people suffering from cardiovascular diseases and to create public awareness of the disease by organising seminars and information campaigns.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.